MaxCyte, Inc.
Status: Publicly traded
Direct answer
MaxCyte, Inc. is publicly traded on NASDAQ under the ticker MXCT.
MaxCyte, Inc. is a global life sciences enterprise focused on the innovation, advancement, and commercialization of next-generation cell therapies. The company offers a suite of advanced electroporation systems, including the ExPERT ATx, a static device for small to medium-scale cell transfection; the ExPERT STx, which uses flow electroporation to support protein production, drug development, and the expression of...
Can you invest in MaxCyte, Inc.?
Yes. MaxCyte, Inc. is publicly traded on NASDAQ under the ticker MXCT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for MaxCyte, Inc.
Detailed equity research is provided by MarketSnap.